These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35575598)

  • 61. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
    Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.
    Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA
    JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Physician Financial Incentives for Use of Outpatient Intravenous Antimicrobial Therapy: An Interrupted Time Series Analysis.
    Staples JA; Ho M; Ferris D; Liu G; Brubacher JR; Khan M; Daly-Grafstein D; Tran KC; Sutherland JM
    Clin Infect Dis; 2023 Jun; 76(12):2098-2105. PubMed ID: 36795054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outpatient parenteral antimicrobial therapy: updated recommendations from the UK.
    Chapman ALN; Patel S; Horner C; Gilchrist M; Seaton RA
    J Antimicrob Chemother; 2019 Nov; 74(11):3125-3127. PubMed ID: 31504575
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement.
    Chapman AL; Seaton RA; Cooper MA; Hedderwick S; Goodall V; Reed C; Sanderson F; Nathwani D;
    J Antimicrob Chemother; 2012 May; 67(5):1053-62. PubMed ID: 22298347
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin.
    Nathwani D
    J Antimicrob Chemother; 2009 Sep; 64(3):447-53. PubMed ID: 19584105
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Outpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of care.
    Yang A; Fung R; Brunton J; Dresser L
    Can J Infect Dis Med Microbiol; 2013; 24(2):74-8. PubMed ID: 24421805
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity.
    Gardiol C; Voumard R; Cochet C; de Vallière S
    Eur J Clin Microbiol Infect Dis; 2016 May; 35(5):839-45. PubMed ID: 26886452
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The first trial of OPAT (outpatient parenteral antimicrobial therapy) with continuous infusions in Japan].
    Hase R; Hosokawa N; Uno S; Mikawa T; Uwamino Y; Muranaka K
    Kansenshogaku Zasshi; 2014 May; 88(3):269-74. PubMed ID: 24974449
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Implementing the First Outpatient Parenteral Antimicrobial Therapy (OPAT) Program to Utilize Disposable Elastomeric Pumps in the Gulf Region: Results From a Tertiary Teaching Hospital in the Kingdom of Saudi Arabia.
    Zikri A; Al-Faraj H; Kamas N; AlZahrani J; BuKhamseen H; Alshahoub W; Beltran A; Fatih D; AlMusa Z
    Cureus; 2021 Dec; 13(12):e20179. PubMed ID: 34900504
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical benefits and costs of an outpatient parenteral antimicrobial therapy service.
    Bugeja SJ; Stewart D; Vosper H
    Res Social Adm Pharm; 2021 Oct; 17(10):1758-1763. PubMed ID: 33551209
    [TBL] [Abstract][Full Text] [Related]  

  • 72. OPAT: proof of concept in a peripheral Belgian hospital after review of the literature.
    Smismans A; Vantrappen A; Verbiest F; Indevuyst C; Van den Poel B; von Winckelmann S; Peeters A; Ombelet S; Lybeert P; Heremans A; Frans E; Ho E; Frans J
    Acta Clin Belg; 2018 Aug; 73(4):257-267. PubMed ID: 29385901
    [TBL] [Abstract][Full Text] [Related]  

  • 73. How is income generated by outpatient parenteral antibiotic treatment (OPAT) in the UK? Analysis of payment tariffs for cellulitis.
    Jones GR; Cumming DV; Honeywell G; Ball R; Sanderson F; Seaton RA; Healy B; Hedderwick S; Gilchrist M;
    J Antimicrob Chemother; 2015 Apr; 70(4):1236-40. PubMed ID: 25558074
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.
    Partridge DG; O'Brien E; Chapman AL
    Postgrad Med J; 2012 Jul; 88(1041):377-81. PubMed ID: 22366395
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antifungal treatment administered in OPAT programs is a safe and effective option in selected patients.
    Gil-Navarro MV; Luque-Marquez R; Báez-Gutiérrez N; Álvarez-Marín R; Navarro-Amuedo MªD; Praena-Segovia J; Carmona-Caballero JM; Fraile-Ramos E; López-Cortés LE
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Dec; 38(10):479-484. PubMed ID: 32143891
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systematic review of stability data pertaining to selected antibiotics used for extended infusions in outpatient parenteral antimicrobial therapy (OPAT) at standard room temperature and in warmer climates.
    Perks SJ; Lanskey C; Robinson N; Pain T; Franklin R
    Eur J Hosp Pharm; 2020 Mar; 27(2):65-72. PubMed ID: 32133131
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predictors of Unplanned Hospitalization in Patients Receiving Outpatient Parenteral Antimicrobial Therapy Across a Large Integrated Healthcare Network.
    Schmidt M; Hearn B; Gabriel M; Spencer MD; McCurdy L
    Open Forum Infect Dis; 2017; 4(2):ofx086. PubMed ID: 28638844
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Outpatient Parenteral Antimicrobial Therapy and Judicious Use of Pediatric Emergency Resources.
    Xu M; Doan Q
    Pediatr Emerg Care; 2020 May; 36(5):e247-e253. PubMed ID: 28697159
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety of Outpatient Parenteral Antimicrobial Therapy in Children.
    Fernandes P; Milliren C; Mahoney-West HM; Schwartz L; Lachenauer CS; Nakamura MM
    Pediatr Infect Dis J; 2018 Feb; 37(2):157-163. PubMed ID: 28763427
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An Assessment of an Outpatient Antimicrobial Therapy Program in a Rural Medical Center : A Retrospective Chart Review.
    Burkett MS; Macci Bires A; Cline TW; Knight A
    Crit Care Nurs Q; 2018; 41(2):109-120. PubMed ID: 29494367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.